Keith Isenberg

4.0k total citations · 1 hit paper
51 papers, 2.8k citations indexed

About

Keith Isenberg is a scholar working on Psychiatry and Mental health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Keith Isenberg has authored 51 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 12 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Keith Isenberg's work include Electroconvulsive Therapy Studies (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Treatment of Major Depression (8 papers). Keith Isenberg is often cited by papers focused on Electroconvulsive Therapy Studies (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Treatment of Major Depression (8 papers). Keith Isenberg collaborates with scholars based in United States, Austria and Japan. Keith Isenberg's co-authors include Harold A. Sackeïm, Mark A. Demitrack, Mark S. George, Ziad Nahas, John P. O’Reardon, Colleen Loo, H. Brent Solvason, Philip G. Janicak, Shirlene Sampson and William M. McDonald and has published in prestigious journals such as Neuron, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Keith Isenberg

51 papers receiving 2.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

2007 1.3k citations John P. O’Reardon, H. Brent Solvason et al. Biological Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Isenberg United States	24	1.3k	829	791	619	520	51	2.8k
Wendol Williams United States	17	858 0.6×	489 0.6×	905 1.1×	725 1.2×	210 0.4×	26	2.3k
H. Brent Solvason United States	20	1.8k 1.3×	987 1.2×	2.5k 3.1×	310 0.5×	109 0.2×	29	4.4k
J. F. Wernicke United States	15	1.2k 0.9×	529 0.6×	1.1k 1.4×	567 0.9×	185 0.4×	23	2.3k
Charles H. Large United Kingdom	30	633 0.5×	574 0.7×	846 1.1×	1.2k 1.9×	932 1.8×	75	2.8k
Antonella Pollo Italy	25	328 0.2×	746 0.9×	2.1k 2.6×	292 0.5×	336 0.6×	43	3.0k
Luisella Bocchio‐Chiavetto Italy	31	518 0.4×	596 0.7×	476 0.6×	723 1.2×	814 1.6×	64	3.1k
Joseph I. Friedman United States	28	240 0.2×	1.6k 1.9×	1.1k 1.5×	873 1.4×	683 1.3×	49	4.2k
A. Wauquier Belgium	36	354 0.3×	1.0k 1.2×	1.1k 1.4×	1.7k 2.7×	800 1.5×	131	3.9k
Pei-Chi Tu Taiwan	26	435 0.3×	611 0.7×	1.0k 1.3×	205 0.3×	84 0.2×	60	2.2k
Dean K. Naritoku United States	27	2.0k 1.5×	1.1k 1.3×	1.9k 2.4×	1.4k 2.3×	364 0.7×	57	3.7k

Countries citing papers authored by Keith Isenberg

Since Specialization

Citations

This map shows the geographic impact of Keith Isenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Isenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Isenberg more than expected).

Fields of papers citing papers by Keith Isenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Isenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Isenberg. The network helps show where Keith Isenberg may publish in the future.

Co-authorship network of co-authors of Keith Isenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Isenberg. A scholar is included among the top collaborators of Keith Isenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Isenberg. Keith Isenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crowe, Christopher L., et al.. (2024). Real-world healthcare resource utilization, costs, and predictors of relapse among US patients with incident schizophrenia or schizoaffective disorder. SHILAP Revista de lepidopterología. 10(1). 86–86. 3 indexed citations

Hunter, Theresa, April N. Naegeli, Michael Grabner, et al.. (2023). Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn’s disease and ulcerative colitis in the United States. BMC Gastroenterology. 23(1). 63–63. 5 indexed citations

Hunter, Theresa, Julie Birt, Joseph A. Smith, et al.. (2021). Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational Study. Rheumatology and Therapy. 8(3). 1371–1382. 12 indexed citations

Eisenberg, D., et al.. (2013). Treatment and Healthcare Utilization Among Commercially Insured Patients With Major Depressive Disorder. The American Journal of Managed Care. 5. 1 indexed citations

McCall, W. Vaughn, David M. Reboussin, Joan Prudic, et al.. (2012). Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT. Journal of Affective Disorders. 147(1-3). 107–111. 17 indexed citations

McCall, W. Vaughn, Peter B. Rosenquist, James Kimball, et al.. (2011). Health-Related Quality of Life in a Clinical Trial of ECT Followed by Continuation Pharmacotherapy. Journal of Ect. 27(2). 97–102. 22 indexed citations

Sackeïm, Harold A., Joan Prudic, Thomas B. Cooper, et al.. (2009). Effect of Concomitant Pharmacotherapy on Electroconvulsive Therapy Outcomes. Archives of General Psychiatry. 66(7). 729–729. 144 indexed citations

Cicero, Theodore J., et al.. (2009). Co-morbidity and utilization of medical services by pain patients receiving opioid medications: Data from an insurance claims database. Pain. 144(1). 20–27. 86 indexed citations

O’Reardon, John P., H. Brent Solvason, Philip G. Janicak, et al.. (2007). Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial. Biological Psychiatry. 62(11). 1208–1216. 1282 indexed citations breakdown →

10.

Mamah, Daniel, Markus Lämmle, & Keith Isenberg. (2005). Pulmonary Embolism After ECT. Journal of Ect. 21(1). 39–40. 24 indexed citations

11.

Thio, Liu Lin, et al.. (2003). Benzodiazepines Block α₂-Containing Inhibitory Glycine Receptors in Embryonic Mouse Hippocampal Neurons. Journal of Neurophysiology. 90(1). 89–99. 30 indexed citations

12.

Isenberg, Keith, et al.. (1998). ECT with Implantable Cardioverter Defibrillator. Journal of Ect. 14(2). 124???126–124???126. 11 indexed citations

13.

Thomas, James L., Gustavo Blanco, Robert W. Mercer, et al.. (1998). Site-directed mutagenesis identifies amino acid residues associated with the dehydrogenase and isomerase activities of human type I (placental) 3β-hydroxysteroid dehydrogenase/Isomerase. The Journal of Steroid Biochemistry and Molecular Biology. 66(5-6). 327–334. 34 indexed citations

14.

Parsian, Abbas, Keith Isenberg, Carol L. Hampe, et al.. (1997). No evidence for a schizophrenia susceptibility gene in the vicinity of IL2RB on chromosome 22. American Journal of Medical Genetics. 74(4). 361–364. 13 indexed citations

15.

Wong, Eric T., et al.. (1995). Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, α3β4, expressed in transfected eucaryotic cells. Molecular Brain Research. 28(1). 101–109. 66 indexed citations

16.

Covey, Douglas F., et al.. (1993). Modulation of GABAA receptor function by benz[e]indenes and phenanthrenes. Journal of Medicinal Chemistry. 36(5). 627–630. 15 indexed citations

17.

Aschauer, H.N., Georg Fischer, Keith Isenberg, et al.. (1993). No proof of linkage between schizophrenia-related disorders including schizophrenia and chromosome 2q21 region. European Archives of Psychiatry and Clinical Neuroscience. 243(3-4). 193–198. 19 indexed citations

18.

Holstad, Sheldon G., et al.. (1993). Oligonucleotide Pharmacotherapy: An Antigene Strategy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(3). 177–188. 27 indexed citations

19.

Isenberg, Keith, et al.. (1993). Partial cDNA cloning and NGF regulation of a rat 5-HT3 receptor subunit. Neuroreport. 5(2). 121–124. 51 indexed citations

20.

Aschauer, H.N., Keith Isenberg, Richard D. Todd, et al.. (1990). No Evidence for Linkage between Chromosome 5 Markers and Schizophrenia. Human Heredity. 40(2). 109–115. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact